Ardelyx Provides Update on FDA Appeal for XPHOZAH® (tenapanor) for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

Stock Information for Ardelyx Inc.

Loading

Please wait while we load your information from QuoteMedia.